OCTOCRYLENE, AVOBENZONE

OCTOCRYLENE, AVOBENZONE was reported 445 times

OCTOCRYLENE, AVOBENZONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LACRIMAL STRUCTURAL DISORDER 4 0.1290
1 DYSMEGAKARYOPOIESIS 1 0.0833
2 BIOPSY ARTERY 1 0.0667
3 CIRCULATING ANTICOAGULANT 1 0.0526
4 APPLICATION SITE PIGMENTATION CHANGES 1 0.0323
5 EYE DEGENERATIVE DISORDER 4 0.0241
6 LACRIMAL DUCT PROCEDURE 1 0.0233
7 URINARY BLADDER ABSCESS 1 0.0222
8 RADIAL NERVE INJURY 1 0.0122
9 PHARYNGO-OESOPHAGEAL DIVERTICULUM 1 0.0110
10 DILATED PORES 1 0.0110
11 PNEUMATURIA 1 0.0104
12 PROCTOCOLITIS 1 0.0098
13 BLOOD METHAEMOGLOBIN PRESENT 1 0.0090
14 RECTAL INJURY 1 0.0088
15 CHEMICAL INJURY 6 0.0073
16 BACTERIAL ABDOMINAL INFECTION 1 0.0068
17 ERYTHROPOIESIS ABNORMAL 2 0.0065
18 ADNEXA UTERI CYST 1 0.0062
19 EYE OPERATION COMPLICATION 1 0.0061
20 ANAL SKIN TAGS 1 0.0061
21 TOOTH HYPOPLASIA 1 0.0057
22 OCULAR ROSACEA 1 0.0049
23 HEAVY EXPOSURE TO ULTRAVIOLET LIGHT 1 0.0047
24 GENITAL DISORDER MALE 1 0.0047
25 TARSAL TUNNEL SYNDROME 1 0.0045
26 ECZEMA ASTEATOTIC 2 0.0042
27 INJECTION SITE NERVE DAMAGE 1 0.0042
28 STOMA SITE ABSCESS 1 0.0041
29 ROSACEA 17 0.0036
30 ORTHOSIS USER 1 0.0036
31 RECTAL ADENOCARCINOMA 2 0.0033
32 LITHIASIS 1 0.0033
33 ACUTE STRESS DISORDER 1 0.0030
34 UTERINE NEOPLASM 1 0.0030
35 RADIAL NERVE PALSY 1 0.0028
36 HEART VALVE STENOSIS 1 0.0028
37 ACCELERATED HYPERTENSION 1 0.0026
38 ILEITIS 1 0.0026
39 AMMONIA ABNORMAL 1 0.0025
40 SKIN FRAGILITY 6 0.0025
41 LICHENIFICATION 1 0.0024
42 FACIAL NERVE DISORDER 1 0.0023
43 ALLERGY TO ARTHROPOD STING 1 0.0022
44 ECZEMA NUMMULAR 1 0.0020
45 CAPILLARY FRAGILITY 1 0.0020
46 PATELLOFEMORAL PAIN SYNDROME 1 0.0019
47 SEBORRHOEA 7 0.0019
48 SKIN DISCOMFORT 5 0.0019
49 INFECTION SUSCEPTIBILITY INCREASED 4 0.0018
50 BACTERIURIA 1 0.0018
51 AMBLYOPIA 1 0.0017
52 AURICULAR SWELLING 1 0.0017
53 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 1 0.0016
54 CELLULITIS STAPHYLOCOCCAL 1 0.0015
55 HAND DERMATITIS 1 0.0014
56 CONNECTIVE TISSUE DISORDER 2 0.0014
57 EYELID MARGIN CRUSTING 4 0.0014
58 PALMOPLANTAR KERATODERMA 1 0.0014
59 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
60 SERRATIA INFECTION 1 0.0013
61 ENTEROVESICAL FISTULA 1 0.0013
62 SKIN TIGHTNESS 6 0.0013
63 PNEUMONIA MYCOPLASMAL 1 0.0013
64 REBOUND EFFECT 14 0.0012
65 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1 0.0012
66 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
67 GUTTATE PSORIASIS 1 0.0012
68 INJECTION SITE ATROPHY 2 0.0012
69 SKIN WARM 7 0.0012
70 JC VIRUS TEST POSITIVE 1 0.0012
71 FOOD REFUSAL 1 0.0011
72 SKIN HYPOPIGMENTATION 2 0.0011
73 APPLICATION SITE DERMATITIS 1 0.0011
74 SOLAR LENTIGO 1 0.0011
75 SKIN TEXTURE ABNORMAL 1 0.0010
76 EYELID PAIN 2 0.0010
77 SKIN SENSITISATION 1 0.0010
78 ONYCHOMADESIS 4 0.0010
79 GALLBLADDER ENLARGEMENT 1 0.0009
80 AMAUROSIS FUGAX 1 0.0009
81 PAIN OF SKIN 25 0.0009
82 HAEMORRHAGIC DISORDER 1 0.0009
83 PERIRECTAL ABSCESS 1 0.0009
84 PUSTULE 2 0.0008
85 EYELID SKIN DRYNESS 1 0.0008
86 MALIGNANT MELANOMA IN SITU 1 0.0008
87 SKIN SWELLING 7 0.0008
88 NASAL DRYNESS 5 0.0008
89 SEROMA 1 0.0008
90 POSTOPERATIVE WOUND COMPLICATION 1 0.0008
91 ACTINIC KERATOSIS 2 0.0008
92 ENCEPHALITIS AUTOIMMUNE 1 0.0008
93 PHARYNGEAL ULCERATION 1 0.0008
94 STENOTROPHOMONAS INFECTION 1 0.0007
95 CORNEAL ABRASION 1 0.0007
96 DISCHARGE 1 0.0007
97 SKIN IRRITATION 33 0.0007
98 PROCTITIS 2 0.0007
99 RASH PAPULAR 16 0.0007
100 INTESTINAL FISTULA 1 0.0007
101 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0007
102 GLUTEN SENSITIVITY 1 0.0007
103 DARK CIRCLES UNDER EYES 1 0.0007
104 COCCYDYNIA 1 0.0007
105 SECONDARY ADRENOCORTICAL INSUFFICIENCY 1 0.0007
106 SKIN BURNING SENSATION 47 0.0007
107 GENITAL HERPES 1 0.0007
108 NEOPLASM SKIN 1 0.0006
109 EYELIDS PRURITUS 2 0.0006
110 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
111 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
112 DERMATITIS CONTACT 7 0.0006
113 DRY SKIN 81 0.0006
114 PAPILLOMA VIRAL INFECTION 1 0.0006
115 SKIN EXFOLIATION 51 0.0006
116 ANXIETY DISORDER 2 0.0006
117 TYMPANIC MEMBRANE PERFORATION 1 0.0006
118 APPLICATION SITE DRYNESS 2 0.0006
119 FOOD AVERSION 1 0.0006
120 SKIN WOUND 1 0.0006
121 FEMALE GENITAL TRACT FISTULA 1 0.0006
122 OTORRHOEA 1 0.0006
123 ERYTHEMA NODOSUM 2 0.0006
124 FEAR OF DISEASE 1 0.0006
125 DERMATITIS ALLERGIC 7 0.0006
126 NASAL OEDEMA 1 0.0006
127 FAECES SOFT 4 0.0005
128 ESSENTIAL HYPERTENSION 1 0.0005
129 BLOOD CHOLESTEROL DECREASED 1 0.0005
130 SUNBURN 4 0.0005
131 LIP DISORDER 1 0.0005
132 BILE DUCT OBSTRUCTION 1 0.0005
133 SCAB 6 0.0005
134 DERMATITIS 11 0.0005
135 RASH MACULAR 18 0.0005
136 PURULENCE 1 0.0005
137 HYPOGEUSIA 1 0.0005
138 OCCULT BLOOD POSITIVE 1 0.0005
139 MULTI-ORGAN DISORDER 1 0.0005
140 DEVICE RELATED SEPSIS 1 0.0005
141 RHINITIS 4 0.0005
142 EYE DISCHARGE 5 0.0005
143 SKIN FISSURES 9 0.0005
144 APHTHOUS STOMATITIS 1 0.0004
145 ERYTHEMA 88 0.0004
146 EYE INFLAMMATION 4 0.0004
147 PULSE ABNORMAL 1 0.0004
148 LEARNING DISORDER 1 0.0004
149 LYMPHADENITIS 1 0.0004
150 RASH PUSTULAR 3 0.0004
151 ACNE 31 0.0004
152 INFLAMMATORY BOWEL DISEASE 4 0.0004
153 APPLICATION SITE SWELLING 2 0.0004
154 HYPERPARATHYROIDISM SECONDARY 1 0.0004
155 EYELID IRRITATION 1 0.0004
156 VASODILATATION 1 0.0004
157 PLATELET DISORDER 1 0.0004
158 DYSLIPIDAEMIA 2 0.0004
159 MENOPAUSE 1 0.0004
160 RETINAL DISORDER 1 0.0004
161 EXFOLIATIVE RASH 1 0.0004
162 WHITE BLOOD CELL DISORDER 1 0.0004
163 ANAL ABSCESS 2 0.0004
164 SKIN WRINKLING 1 0.0004
165 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
166 SERUM SICKNESS 1 0.0004
167 RENAL TUBULAR DISORDER 1 0.0004
168 EYE INFECTION 4 0.0004
169 OESOPHAGEAL STENOSIS 1 0.0004
170 TUMOUR HAEMORRHAGE 1 0.0004
171 EYELID OEDEMA 4 0.0003
172 ACNE CYSTIC 1 0.0003
173 CRANIOCEREBRAL INJURY 1 0.0003
174 EMBOLISM VENOUS 1 0.0003
175 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
176 PIGMENTATION DISORDER 2 0.0003
177 IRIDOCYCLITIS 1 0.0003
178 FEELING HOT 19 0.0003
179 SKIN INJURY 1 0.0003
180 RASH ERYTHEMATOUS 14 0.0003
181 CROHN'S DISEASE 2 0.0003
182 TACHYPHRENIA 1 0.0003
183 MICTURITION DISORDER 1 0.0003
184 HYPOPNOEA 1 0.0003
185 CAROTID ARTERY STENOSIS 1 0.0003
186 THROMBOPHLEBITIS 1 0.0003
187 MACULOPATHY 1 0.0003
188 FIBRIN D DIMER INCREASED 1 0.0003
189 SPONDYLITIS 1 0.0003
190 SENSITIVE SKIN 2 0.0003
191 CONJUNCTIVITIS 5 0.0003
192 CATHETER SITE INFECTION 1 0.0003
193 PARANASAL SINUS HYPERSECRETION 1 0.0003
194 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
195 DRY EYE 13 0.0003
196 RENAL FAILURE CHRONIC 2 0.0003
197 METASTASES TO LUNG 3 0.0003
198 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
199 PANIC DISORDER 1 0.0003
200 APHTHOUS ULCER 2 0.0003
201 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
202 FAECES HARD 1 0.0003
203 ORAL INFECTION 1 0.0003
204 POLYDIPSIA 1 0.0003
205 RENAL CYST 2 0.0003
206 ECZEMA 13 0.0002
207 PERIPHERAL VENOUS DISEASE 1 0.0002
208 GOITRE 1 0.0002
209 DEMYELINATION 1 0.0002
210 CARDIAC FAILURE CHRONIC 1 0.0002
211 INTERVERTEBRAL DISC DISORDER 1 0.0002
212 LUNG NEOPLASM 1 0.0002
213 SKIN HYPERPIGMENTATION 2 0.0002
214 HEPATIC LESION 1 0.0002
215 HORDEOLUM 1 0.0002
216 HYSTERECTOMY 2 0.0002
217 CHAPPED LIPS 1 0.0002
218 MONOPLEGIA 1 0.0002
219 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
220 TONGUE DISCOLOURATION 1 0.0002
221 HAEMORRHAGIC ANAEMIA 1 0.0002
222 APPLICATION SITE PAIN 5 0.0002
223 ABDOMINAL ABSCESS 1 0.0002
224 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 16 0.0002
225 IRON DEFICIENCY 1 0.0002
226 LIP DRY 2 0.0002
227 CHRONIC MYELOID LEUKAEMIA 1 0.0002
228 SYNOVIAL CYST 1 0.0002
229 FLUSHING 22 0.0002
230 EYE SWELLING 8 0.0002
231 SWELLING FACE 14 0.0002
232 SPINAL COLUMN STENOSIS 1 0.0002
233 CARDIAC TAMPONADE 1 0.0002
234 GASTROINTESTINAL TOXICITY 1 0.0002
235 ENTEROCOCCAL INFECTION 1 0.0002
236 RASH VESICULAR 1 0.0002
237 SKIN HAEMORRHAGE 3 0.0002
238 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
239 INFLAMMATORY MARKER INCREASED 1 0.0002
240 ANEURYSM 1 0.0002
241 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
242 PHLEBITIS 1 0.0002
243 INITIAL INSOMNIA 2 0.0002
244 PERIPHERAL VASCULAR DISORDER 1 0.0002
245 VARICOSE VEIN 1 0.0002
246 ANORECTAL DISCOMFORT 1 0.0002
247 ANAL FISTULA 1 0.0002
248 ANAL FISSURE 1 0.0002
249 CHEILITIS 1 0.0002
250 PALLOR 5 0.0002
251 JAW DISORDER 1 0.0002
252 CHOKING SENSATION 1 0.0002
253 HYPERKERATOSIS 1 0.0002
254 FOOT DEFORMITY 2 0.0002
255 FEELING COLD 5 0.0002
256 HAEMOPTYSIS 5 0.0002
257 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
258 SCAR 3 0.0002
259 NEUROLOGICAL SYMPTOM 1 0.0002
260 SKIN DISCOLOURATION 8 0.0002
261 METABOLIC DISORDER 1 0.0002
262 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
263 DERMATITIS ATOPIC 9 0.0002
264 URINE ODOUR ABNORMAL 1 0.0002
265 HYPERCHLORHYDRIA 1 0.0002
266 PROTHROMBIN TIME PROLONGED 1 0.0002
267 MENTAL IMPAIRMENT 4 0.0002
268 ADRENAL INSUFFICIENCY 2 0.0002
269 DERMATITIS ACNEIFORM 1 0.0002
270 MENISCUS INJURY 1 0.0002
271 SCOLIOSIS 1 0.0002
272 SWELLING OF EYELID 1 0.0002
273 EYE IRRITATION 9 0.0002
274 ENTERITIS 1 0.0002
275 BREAST CANCER STAGE III 1 0.0002
276 POLYP 1 0.0002
277 PRODUCT PREPARATION ISSUE 1 0.0002
278 INCORRECT PRODUCT STORAGE 2 0.0002
279 PRODUCT FORMULATION ISSUE 1 0.0002
280 ADVERSE REACTION 2 0.0002
281 VISUAL ACUITY REDUCED 5 0.0002
282 LIP SWELLING 5 0.0001
283 POST-TRAUMATIC STRESS DISORDER 1 0.0001
284 METASTASES TO LYMPH NODES 1 0.0001
285 POSTOPERATIVE WOUND INFECTION 1 0.0001
286 BLOOD TESTOSTERONE DECREASED 1 0.0001
287 ECCHYMOSIS 1 0.0001
288 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
289 PRURITUS 56 0.0001
290 LARGE INTESTINE POLYP 1 0.0001
291 EXTRASYSTOLES 1 0.0001
292 BURNING SENSATION 10 0.0001
293 APPLICATION SITE REACTION 1 0.0001
294 OSTEOARTHRITIS 6 0.0001
295 THERMAL BURN 1 0.0001
296 DIVERTICULUM 1 0.0001
297 IRRITABLE BOWEL SYNDROME 3 0.0001
298 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
299 PANIC REACTION 1 0.0001
300 DERMATITIS BULLOUS 1 0.0001
301 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
302 MAJOR DEPRESSION 1 0.0001
303 ORAL DISORDER 1 0.0001
304 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
305 ORAL PAIN 3 0.0001
306 PROCEDURAL COMPLICATION 1 0.0001
307 PHARYNGEAL OEDEMA 2 0.0001
308 FOOD ALLERGY 1 0.0001
309 MUSCULOSKELETAL CHEST PAIN 2 0.0001
310 MULTIPLE ALLERGIES 1 0.0001
311 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
312 NASAL DISCOMFORT 1 0.0001
313 CONDITION AGGRAVATED 38 0.0001
314 BLISTER 7 0.0001
315 DECUBITUS ULCER 1 0.0001
316 HICCUPS 1 0.0001
317 ESCHERICHIA INFECTION 1 0.0001
318 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
319 CELLULITIS 6 0.0001
320 FACE OEDEMA 2 0.0001
321 SKIN PLAQUE 1 0.0001
322 CANDIDA INFECTION 2 0.0001
323 INADEQUATE ANALGESIA 1 0.0001
324 PSEUDOMONAS INFECTION 1 0.0001
325 SKIN ULCER 3 0.0001
326 MUSCLE STRAIN 1 0.0001
327 APPLICATION SITE ERYTHEMA 3 0.0001
328 ARTHRITIS 9 0.0001
329 NAIL DISORDER 1 0.0001
330 SPINAL OSTEOARTHRITIS 1 0.0001
331 METASTASES TO LIVER 2 0.0001
332 FACIAL PAIN 1 0.0001
333 HAEMARTHROSIS 1 0.0001
334 THROAT IRRITATION 5 0.0001
335 DRUG EFFECT DECREASED 6 0.0001
336 ANAL INCONTINENCE 1 0.0001
337 DYSURIA 4 0.0001
338 SPINAL DISORDER 1 0.0001
339 SPUTUM DISCOLOURED 1 0.0001
340 HYPERCHOLESTEROLAEMIA 1 0.0001
341 EAR PAIN 2 0.0001
342 VITAMIN D DEFICIENCY 1 0.0001
343 RENAL TUBULAR NECROSIS 1 0.0001
344 KIDNEY INFECTION 2 0.0001
345 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
346 HOSPICE CARE 1 0.0001
347 SINUS DISORDER 2 0.0001
348 HYPOTHERMIA 1 0.0001
349 DRY THROAT 1 0.0001
350 SUBARACHNOID HAEMORRHAGE 1 0.0001
351 BODY TEMPERATURE INCREASED 2 0.0001
352 EAR DISCOMFORT 1 0.0001
353 TEMPERATURE INTOLERANCE 1 0.0001
354 NERVOUS SYSTEM DISORDER 3 0.0001
355 TENDERNESS 1 0.0001
356 PETECHIAE 1 0.0001
357 WEIGHT FLUCTUATION 1 0.0001
358 INCONTINENCE 1 0.0001
359 JOINT DISLOCATION 1 0.0001
360 CYSTITIS 3 0.0001
361 HYPOTHYROIDISM 3 0.0001
362 RETCHING 2 0.0001
363 NIGHT SWEATS 3 0.0001
364 RHINORRHOEA 6 0.0001
365 DECREASED ACTIVITY 1 0.0001
366 MENSTRUATION DELAYED 1 0.0001
367 RASH PRURITIC 5 0.0001
368 BACK INJURY 1 0.0001
369 PULMONARY THROMBOSIS 1 0.0001
370 IMPAIRED HEALING 3 0.0001
371 EXPIRED PRODUCT ADMINISTERED 3 0.0001
372 GASTROINTESTINAL DISORDER 8 0.0001
373 SKIN INFECTION 1 0.0001
374 OCULAR DISCOMFORT 1 0.0001
375 BLOOD CALCIUM DECREASED 1 0.0001
376 APPLICATION SITE PRURITUS 2 0.0001
377 RASH 38 0.0001
378 GASTRIC HAEMORRHAGE 1 0.0001
379 PERICARDIAL EFFUSION 2 0.0001
380 ELECTROLYTE IMBALANCE 1 0.0001
381 PRODUCT USE ISSUE 16 0.0001
382 LYMPHADENOPATHY 3 0.0001
383 DYSPHAGIA 8 0.0001
384 MACULAR DEGENERATION 1 0.0001
385 EMOTIONAL DISTRESS 10 0.0001
386 BURSITIS 1 0.0001
387 PRESYNCOPE 2 0.0001
388 SMALL INTESTINAL OBSTRUCTION 1 0.0001
389 HYPERCALCAEMIA 1 0.0001
390 CYST 1 0.0001
391 APPLICATION SITE IRRITATION 1 0.0001
392 SECRETION DISCHARGE 1 0.0001
393 HOT FLUSH 6 0.0001
394 FLUID RETENTION 4 0.0001
395 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
396 RASH GENERALISED 2 0.0001
397 NASOPHARYNGITIS 14 0.0001
398 ORAL CANDIDIASIS 1 0.0001
399 TOOTH INFECTION 1 0.0001
400 PULMONARY CONGESTION 1 0.0001
401 OROPHARYNGEAL PAIN 7 0.0001
402 CORONARY ARTERY OCCLUSION 1 0.0001
403 ORAL DISCOMFORT 1 0.0001
404 HUNGER 1 0.0001
405 CARPAL TUNNEL SYNDROME 1 0.0001
406 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
407 SKIN REACTION 1 0.0001
408 LYMPHOPENIA 1 0.0001
409 SEASONAL ALLERGY 1 0.0001
410 SINUS TACHYCARDIA 1 0.0001
411 INTENTIONAL DOSE OMISSION 2 0.0001
412 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
413 PRODUCT SUBSTITUTION ISSUE 4 0.0001
414 PARAESTHESIA ORAL 1 0.0001
415 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
416 GASTROENTERITIS 1 0.0001
417 HAEMORRHAGE INTRACRANIAL 1 0.0001
418 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
419 EPISTAXIS 5 0.0001
420 HYPOAESTHESIA 10 0.0001
421 HYPOAESTHESIA ORAL 1 0.0001
422 APHASIA 2 0.0001
423 LACRIMATION INCREASED 2 0.0001
424 THERAPEUTIC RESPONSE DECREASED 4 0.0001
425 CHRONIC KIDNEY DISEASE 5 0.0001
426 PLEURAL EFFUSION 4 0.0001
427 DISCOMFORT 4 0.0001
428 INJECTION SITE RASH 2 0.0001
429 HYPOKALAEMIA 3 0.0001
430 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
431 TENDONITIS 1 0.0001
432 DELUSION 1 0.0001
433 ACUTE MYELOID LEUKAEMIA 1 0.0001
434 SWOLLEN TONGUE 2 0.0001
435 OCULAR HYPERAEMIA 3 0.0001
436 ULCER 1 0.0001
437 PRODUCTIVE COUGH 3 0.0001
438 OBESITY 1 0.0001
439 ABSCESS 1 0.0001
440 SENSORY DISTURBANCE 1 0.0001
441 DRY MOUTH 5 0.0001
442 METASTASES TO BONE 1 0.0001
443 EYE DISORDER 2 0.0001
444 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
445 SKIN DISORDER 2 0.0001
446 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
447 HEPATIC ENZYME INCREASED 4 0.0001
448 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
449 ORTHOSTATIC HYPOTENSION 1 0.0001
450 COLD SWEAT 1 0.0001
451 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
452 LYMPHOCYTE COUNT DECREASED 1 0.0001
453 GALLBLADDER DISORDER 1 0.0001
454 DRUG EFFECT INCOMPLETE 2 0.0001
455 END STAGE RENAL DISEASE 1 0.0001
456 UNDERDOSE 4 0.0001
457 HAEMATOCHEZIA 3 0.0001
458 HYPERSENSITIVITY 10 0.0001
459 THINKING ABNORMAL 1 0.0001
460 BACTERIAL INFECTION 1 0.0001
461 PSORIASIS 7 0.0001
462 HYPOCALCAEMIA 1 0.0001
463 COLITIS 2 0.0001
464 MUSCULOSKELETAL DISORDER 1 0.0001
465 ANAEMIA 10 0.0001
466 SLEEP APNOEA SYNDROME 1 0.0001
467 MIGRAINE 5 0.0001
468 POST PROCEDURAL COMPLICATION 1 0.0001
469 ACUTE RESPIRATORY FAILURE 1 0.0001
470 CONTUSION 5 0.0001
471 ERUCTATION 1 0.0001
472 HAEMORRHOIDS 1 0.0001
473 ORAL HERPES 1 0.0001
474 NASAL CONGESTION 3 0.0001
475 MENORRHAGIA 1 0.0001
476 DISABILITY 1 0.0001
477 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
478 SPINAL FRACTURE 1 0.0000
479 STOMATITIS 3 0.0000
480 PSORIATIC ARTHROPATHY 2 0.0000
481 VERTIGO 3 0.0000
482 PYREXIA 17 0.0000
483 MOUTH ULCERATION 1 0.0000
484 HALLUCINATION, VISUAL 1 0.0000
485 IMPAIRED WORK ABILITY 1 0.0000
486 RECTAL HAEMORRHAGE 2 0.0000
487 POOR QUALITY SLEEP 1 0.0000
488 COUGH 13 0.0000
489 PRURITUS GENERALISED 1 0.0000
490 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
491 INSOMNIA 12 0.0000
492 HYPOTENSION 9 0.0000
493 COLITIS ULCERATIVE 2 0.0000
494 SNEEZING 1 0.0000
495 CHROMATURIA 1 0.0000
496 RHEUMATOID ARTHRITIS 5 0.0000
497 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
498 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
499 BLOOD CHOLESTEROL INCREASED 2 0.0000
500 SLEEP DISORDER 3 0.0000
501 URTICARIA 7 0.0000
502 BLOOD PRESSURE FLUCTUATION 1 0.0000
503 FIBROMYALGIA 1 0.0000
504 OEDEMA PERIPHERAL 5 0.0000
505 ALOPECIA 8 0.0000
506 DYSGEUSIA 3 0.0000
507 DRUG INEFFECTIVE 53 0.0000
508 DEPRESSION 9 0.0000
509 HYPOPHAGIA 1 0.0000
510 HEPATITIS 1 0.0000
511 CHEST DISCOMFORT 4 0.0000
512 ANAPHYLACTIC SHOCK 1 0.0000
513 INFLAMMATION 2 0.0000
514 EXPOSURE VIA SKIN CONTACT 1 0.0000
515 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
516 DIPLOPIA 1 0.0000
517 HAEMORRHAGE 4 0.0000
518 DEAFNESS 1 0.0000
519 MUCOSAL INFLAMMATION 1 0.0000
520 PARAESTHESIA 6 0.0000
521 JOINT STIFFNESS 1 0.0000
522 GASTRITIS 1 0.0000
523 EAR INFECTION 1 0.0000
524 THROAT TIGHTNESS 1 0.0000
525 INFLUENZA LIKE ILLNESS 3 0.0000
526 RESPIRATORY DISTRESS 1 0.0000
527 DIVERTICULITIS 1 0.0000
528 MENTAL STATUS CHANGES 1 0.0000
529 ARTHROPATHY 2 0.0000
530 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
531 INJECTION SITE PAIN 11 0.0000
532 WOUND 1 0.0000
533 DIARRHOEA 23 0.0000
534 ASTHMA 4 0.0000
535 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
536 FLATULENCE 2 0.0000
537 URINARY TRACT INFECTION 6 0.0000
538 HYPERSOMNIA 1 0.0000
539 HERPES ZOSTER 2 0.0000
540 LETHARGY 2 0.0000
541 BALANCE DISORDER 3 0.0000
542 DYSSTASIA 1 0.0000
543 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
544 MUSCULOSKELETAL STIFFNESS 3 0.0000
545 PALPITATIONS 4 0.0000
546 PSYCHOTIC DISORDER 1 0.0000
547 ARTHRALGIA 14 0.0000
548 PERIPHERAL SWELLING 5 0.0000
549 EMOTIONAL DISORDER 1 0.0000
550 LIMB DISCOMFORT 1 0.0000
551 WEIGHT DECREASED 9 0.0000
552 CONSTIPATION 7 0.0000
553 VOMITING 15 0.0000
554 HEADACHE 20 0.0000
555 PULMONARY EMBOLISM 3 0.0000
556 NEUROPATHY PERIPHERAL 3 0.0000
557 MOVEMENT DISORDER 1 0.0000
558 PAIN 19 0.0000
559 LACTIC ACIDOSIS 1 0.0000
560 BLOOD CREATININE INCREASED 2 0.0000
561 STAPHYLOCOCCAL INFECTION 1 0.0000
562 ABDOMINAL PAIN 7 0.0000
563 DIZZINESS 15 0.0000
564 VIRAL INFECTION 1 0.0000
565 FUNGAL INFECTION 1 0.0000
566 INJECTION SITE PRURITUS 2 0.0000
567 EYE PRURITUS 1 0.0000
568 TYPE 2 DIABETES MELLITUS 1 0.0000
569 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
570 ANGER 1 0.0000
571 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
572 HAEMATURIA 1 0.0000
573 VISION BLURRED 4 0.0000
574 NAUSEA 23 0.0000
575 DELIRIUM 1 0.0000
576 DEVICE USE ERROR 1 0.0000
577 HYPOXIA 1 0.0000
578 PLATELET COUNT DECREASED 3 0.0000
579 PRODUCT ADHESION ISSUE 1 0.0000
580 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
581 MOBILITY DECREASED 2 0.0000
582 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
583 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
584 C-REACTIVE PROTEIN INCREASED 1 0.0000
585 HYPERGLYCAEMIA 1 0.0000
586 AGITATION 2 0.0000
587 CHEST PAIN 5 0.0000
588 FATIGUE 21 0.0000
589 INTESTINAL OBSTRUCTION 1 0.0000
590 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
591 DECREASED APPETITE 6 0.0000
592 CHILLS 3 0.0000
593 ABNORMAL BEHAVIOUR 1 0.0000
594 DISORIENTATION 1 0.0000
595 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
596 OSTEOPOROSIS 1 0.0000
597 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
598 VISUAL IMPAIRMENT 3 0.0000
599 CARDIO-RESPIRATORY ARREST 1 0.0000
600 ABDOMINAL DISCOMFORT 4 0.0000
601 RENAL FAILURE ACUTE 1 0.0000
602 VAGINAL HAEMORRHAGE 1 0.0000
603 SEPTIC SHOCK 1 0.0000
604 DYSPNOEA 13 0.0000
605 INTENTIONAL PRODUCT MISUSE 2 0.0000
606 TACHYCARDIA 2 0.0000
607 DEHYDRATION 3 0.0000
608 PULMONARY OEDEMA 1 0.0000
609 WEIGHT INCREASED 5 0.0000
610 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
611 PRODUCT QUALITY ISSUE 3 0.0000
612 MEMORY IMPAIRMENT 3 0.0000
613 NEPHROLITHIASIS 1 0.0000
614 TINNITUS 1 0.0000
615 OFF LABEL USE 19 0.0000
616 RENAL DISORDER 1 0.0000
617 BREAST CANCER 2 0.0000
618 COGNITIVE DISORDER 1 0.0000
619 ANXIETY 6 0.0000
620 MULTIPLE SCLEROSIS 1 0.0000
621 GAIT DISTURBANCE 4 0.0000
622 INTERSTITIAL LUNG DISEASE 1 0.0000
623 ATRIAL FIBRILLATION 2 0.0000
624 LUNG DISORDER 1 0.0000
625 DYSPEPSIA 2 0.0000
626 LEUKOPENIA 1 0.0000
627 BLOOD PRESSURE INCREASED 3 0.0000
628 ACUTE KIDNEY INJURY 3 0.0000
629 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
630 ABDOMINAL PAIN UPPER 4 0.0000
631 NERVOUSNESS 1 0.0000
632 PANCREATITIS 1 0.0000
633 TREATMENT NONCOMPLIANCE 1 0.0000
634 DRUG DOSE OMISSION 3 0.0000
635 ANAPHYLACTIC REACTION 1 0.0000
636 FALL 6 0.0000
637 NECK PAIN 1 0.0000
638 THROMBOCYTOPENIA 2 0.0000
639 OXYGEN SATURATION DECREASED 1 0.0000
640 HYPONATRAEMIA 1 0.0000
641 EYE PAIN 1 0.0000
642 BACK PAIN 4 0.0000
643 DYSPHONIA 1 0.0000
644 BONE PAIN 1 0.0000
645 WHEEZING 1 0.0000
646 IRRITABILITY 1 0.0000
647 MUSCLE SPASMS 3 0.0000
648 INJECTION SITE ERYTHEMA 2 0.0000
649 MALAISE 7 0.0000
650 LOSS OF CONSCIOUSNESS 2 0.0000
651 HYPERHIDROSIS 2 0.0000
652 DEEP VEIN THROMBOSIS 1 0.0000
653 AMNESIA 1 0.0000
654 NEUTROPENIA 2 0.0000
655 INJURY 1 0.0000
656 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
657 THERAPY INTERRUPTED 1 0.0000
658 INFECTION 2 0.0000
659 RESPIRATORY FAILURE 1 0.0000
660 PRODUCT DOSE OMISSION ISSUE 4 0.0000
661 PAIN IN EXTREMITY 4 0.0000
662 BRONCHITIS 1 0.0000
663 HALLUCINATION 1 0.0000
664 DIABETES MELLITUS 1 0.0000
665 DRUG INTERACTION 2 0.0000
666 FEELING ABNORMAL 3 0.0000
667 CARDIAC FAILURE 1 0.0000
668 THROMBOSIS 1 0.0000
669 PNEUMONIA 4 0.0000
670 CARDIAC ARREST 1 0.0000
671 RENAL IMPAIRMENT 1 0.0000
672 PRODUCT STORAGE ERROR 1 0.0000
673 ADVERSE DRUG REACTION 1 0.0000
674 NO ADVERSE EVENT 2 0.0000
675 ADVERSE EVENT 1 0.0000
676 SWELLING 1 0.0000
677 DRUG INTOLERANCE 1 0.0000
678 HEART RATE INCREASED 1 0.0000
679 SOMNOLENCE 2 0.0000
680 HAEMOGLOBIN DECREASED 1 0.0000
681 ILLNESS 1 0.0000
682 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
683 ABDOMINAL DISTENSION 1 0.0000
684 HYPERTENSION 2 0.0000
685 OVERDOSE 2 0.0000
686 SEPSIS 1 0.0000
687 MUSCULAR WEAKNESS 1 0.0000
688 INCORRECT DOSE ADMINISTERED 2 0.0000
689 SEIZURE 1 0.0000
690 DISEASE PROGRESSION 1 0.0000
691 DEATH 7 0.0000
692 RENAL FAILURE 1 0.0000
693 HOSPITALISATION 1 0.0000
694 CONFUSIONAL STATE 1 0.0000
695 MYOCARDIAL INFARCTION 1 0.0000
696 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
697 ASTHENIA 1 0.0000